Close banner

2022-11-07 17:29:29 By : Ms. Jane Zhao

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

You can also search for this author in PubMed   Google Scholar

You have full access to this article via your institution.

Anopheles stephensi thrives in urban settings. Credit: Soumyabrata Roy/NurPhoto via Getty

Compelling evidence has emerged that a malaria outbreak in Ethiopia this year was caused by the arrival in eastern Africa of an insecticide-resistant species of mosquito (Anopheles stephensi). The finding complicates disease-elimination efforts in Africa — where 95% of the world’s malaria infections occur — and has worried researchers because A. stephensi’s behaviour is different from that of other malaria carriers.

Resistance to front-line malaria drugs confirmed in Africa

Resistance to front-line malaria drugs confirmed in Africa

Outbreaks have been difficult to control in Africa recently because health-care workers and researchers have been focused on the COVID-19 pandemic. From 2019 to 2020, malaria infections in Africa rose by 7%, to about 228 million.

Researchers have been warning that A. stephensi, which is prevalent in southern Asia, could be behind recent malaria surges in eastern Africa. And data presented on 1 November at the annual meeting of the American Society of Tropical Medicine and Hygiene point strongly to the mosquito species being the culprit in the outbreak in Dire Dawa, Ethiopia.

“This is very important work,” says Seth Irish, a medical entomologist at the World Health Organization (WHO) in Geneva, Switzerland. The data are especially convincing, says Jaishree Raman, a molecular biologist at the National Institute for Communicable Diseases in Johannesburg, South Africa, because before A. stephensi arrived, malaria infections had not been common in Dire Dawa. But cases have skyrocketed, from 205 in 2019 to more than 2,400 so far in 2022.

To determine whether A. stephensi is indeed driving the malaria surge in Dire Dawa, Fitsum Tadesse, a molecular biologist at the Armauer Hansen Research Institute in Addis Ababa, Ethiopia, and his colleagues identified 98 residents who had tested positive for the disease. They then tested 213 people who shared a household with those residents, as well as 213 people living with a person who had tested negative. Those in the first group were about four times more likely to also have the disease.

The results suggest that a mosquito, which can pick up malaria parasites from the blood of an infected person and spread them to others nearby, is involved in the outbreak. To pinpoint the exact species, the researchers looked for breeding sites and collected adult mosquitoes from around the homes of those included in the study. About 97% of the adult mosquitoes collected were A. stephensi, and researchers found more breeding sites around the households of those who had tested positive for malaria.

Mosquito nets typically used to protect against contracting malaria indoors might not work against A. stephensi, because it prefers outdoor settings. Credit: Tiksa Negeri/Reuters/Alamy

One reason that scientists have been worried about A. stephensi is that it is adept at breeding in human-made water containers, such as barrels or wells, making urban areas a preferred spot. By contrast, other malaria-carrying mosquitoes often prefer to breed in stagnant puddles and lakes in rural settings. Many African cities are rapidly urbanizing, offering ample opportunities for A. stephensi to find suitable breeding grounds, Irish says. And its larvae are especially resilient, Tadesse says; the mosquito persists even during dry seasons, unlike other malaria carriers, which die off without adequate breeding sites.

Another concern is that A. stephensi prefers outdoor settings to indoor ones, rendering some conventional methods of mosquito control, such as bed nets and household spraying, ineffective. It’s “questionable how feasible malaria elimination is with existing tools”, says Jan Kolaczinski, who leads the vector control and insecticide resistance unit at the WHO’s Global Malaria Programme. Given that A. stephensi is also resistant to common insecticides, such as DDT and pyrethroids, Kolaczinski stresses the importance of thinking outside the box to stop the insect’s spread. He recommends more research into the use of genetically modified mosquitoes to prevent A. stephensi from breeding, for example.

Lessons from treating A. stephensi in India, where the mosquito has caused urban malaria outbreaks, could also help, says Pradeep Srivastava, a former chief of vector control and entomology at the National Center for Vector Borne Diseases Control in Delhi. One strategy that has worked is enacting stricter policies on water storage, he says.

The stakes are high: Djibouti, which neighbours Ethiopia, was on the verge of eliminating malaria from its borders in 2012, when researchers there first encountered A. stephensi. Since then, infections have ballooned, with more than 73,000 reported in 2020. In recent years, the mosquito species has been observed in northern Nigeria, thousands of kilometres across the continent. The WHO issued an alert about A. stephensi in 2019, and this September the agency launched an initiative to stop its spread.

A 2020 analysis1 also found that about 126 million people living in African cities could be at risk of malaria if A. stephensi continues to spread across the continent. The WHO is coordinating a pilot programme to distribute a malaria vaccine that was approved in 2021 for broad use in children. The vaccine, which works by creating antibodies against the most deadly species of malaria parasite (Plasmodium falciparum), will have limited release in Kenya, Malawi and Ghana, and will be available in other malaria-endemic countries by 2025.

“There is no silver bullet” for this fast-spreading malaria vector, Tadesse says. “We need a different approach.”

doi: https://doi.org/10.1038/d41586-022-03540-8

Sinka, M. E. et al. Proc. Natl Acad. Sci. USA 117, 24900–24908 (2020).

Ater COVID, African countries vow to take the fight to malaria

Resistance to front-line malaria drugs confirmed in Africa

Laggard rich countries risk slowing the fight against AIDS, malaria and TB

Lifesaving fund to fight AIDS, malaria and TB falls short of $18-billion target

Malaria vaccine booster prolongs protection

Broad transcriptomic dysregulation occurs across the cerebral cortex in ASD

Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces

Leaders can choose to prevent pandemics

COVID vaccine hoarding might have cost more than a million lives

There’s only one choice in Brazil’s election — for the country and the world

Adapt solar panels for sub-Saharan Africa

East China Normal University (ECNU)

West Coast US; East Coast US; Seoul, South Korea; Europe; Or based in Nanjing, China

Suzhou Medical College of Soochow University

You have full access to this article via your institution.

Ater COVID, African countries vow to take the fight to malaria

Resistance to front-line malaria drugs confirmed in Africa

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Nature (Nature) ISSN 1476-4687 (online) ISSN 0028-0836 (print)